A potent antibody therapy derived from llamas was found to broadly neutralize numerous strains of HIV-1.
![Antibodies from llamas bring scientists closer to an HIV treatment](https://www.advancedsciencenews.com/wp-content/uploads/2024/05/CAp256_R27_lowContour.jpg)
A potent antibody therapy derived from llamas was found to broadly neutralize numerous strains of HIV-1.
A vaccine to prevent melioidosis, a tropical bacterial disease and possible bioterrorism threat, succeeded in initial trials.
An RNA-based vaccine approach that is effective against all virus strains and safe for infants and immunocompromised individuals.
A modification to conventional microscopes pushes the limits of their resolution and enables high-precision observation of difficult-to-observe pathogens.
To curb the rising threat of fungal infections, researchers crafted iron oxide nanoparticles as speedy, effective, and inexpensive antifungal agents.
Revolutionizing respiratory disease detection with a portable E-Nose for non-invasive breath analysis.
Researchers turn to nanotechnology to boost the detection of pathogens, including SARS-CoV-2.
To create a flu vaccine that doesn’t require annual tweaking, researchers develop a nanovaccine that uses an inverted hemagglutinin protein.
The genetic variant that causes Gaucher disease may have helped breakdown tuberculosis-causing bacteria in cells through lipid buildup.
A new antibacterial surface treatment could help improve the safety of medical devices by minimizing the risk of infection during their use.